Acetate

Overview

Acetate (acetic acid, C2) is the most abundant SCFA in the colon (~60% of total SCFAs) and the primary cross-feeding substrate for butyrate production. Produced by Bacteroides, Bifidobacterium, Prevotella, and acetogens from dietary fiber fermentation, acetate reaches portal concentrations of 100–300 µM and peripheral circulation at 50–200 µM — making it the only SCFA with significant systemic concentrations.

Functions

  • cross feeding substrate: Acetate is converted to butyrate by butyrate-producing Firmicutes (roseburia, faecalibacterium prausnitzii) via butyryl-CoA:acetate CoA-transferase. This acetate→butyrate chain means acetate producers are upstream of the entire butyrate-dependent protective cascade [1].
  • Appetite regulation: Acetate crosses the blood-brain barrier and reduces appetite via hypothalamic signaling.
  • Immune modulation: Activates GPR43 (FFAR2) on immune cells, promoting neutrophil recruitment and Treg differentiation.
  • Histone acetylation: Systemic acetate contributes to histone H3/H4 acetylation in peripheral tissues — an epigenetic mechanism linking gut microbiome to systemic gene regulation.
  • Cancer: Context-dependent effects — anti-proliferative via HDAC inhibition in some cancers, but Acetyl-CoA supply for lipogenesis in others [2].

Cross-References

References (4)

  1. Louis P, et al. (2022). Louis et al. 2022 — Microbial Lactate Utilisation and the Stability of the Gut Microbiome. Gut Microbiome. doi:10.1017/gmb.2022.3
  2. Mark A. Feitelson, Alla Arzumanyan, Arvin Medhat et al. (2023). Short-chain fatty acids in cancer pathogenesis. Cancer and Metastasis Reviews. doi:10.1007/s10555-023-10117-y
  3. Fiona C. Ross, Dhrati Patangia, Ghjuvan Grimaud et al. (2024). The interplay between diet and the gut microbiome: implications for health and disease. Nature Reviews Microbiology
  4. Yingdong Lu, Yang Zhang, Xin Zhao et al. (2022). Microbiota-derived short-chain fatty acids: Implications for cardiovascular and metabolic disease. Frontiers in Cardiovascular Medicine. doi:10.3389/fcvm.2022.900381